Feasibility of trained non-medical professionals performing laser treatment for PDR and impact on service delivery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project examines if non-medical eye care professionals can carry out laser therapy for proliferative diabetic retinopathy in line with standard protocols. It aims to determine feasibility, acceptability, and potential effects on service capacity, to inform a future larger trial comparing trained clinicians with ophthalmologists. The study will enroll adults with diabetes and active PDR who are new referrals, while excluding those with factors that could complicate laser treatment or retina visualization. Outcomes will focus on safety, practicality, and workflow implications in a real-world clinical setting. No results are reported at this stage; findings will guide future research planning.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* People with diabetes
* Proliferative diabetic retinopathy
* Aged18 years or over
* New referrals

Exclusion Criteria:

* Follow up appointments i.e. treatment already started
* Eye complications which may make laser treatment difficult
* Vitreous haemorrhage
* Dense media opacity
* Eye care complications which prevent a view of the retina

Where it's running

• Swansea Bay University Health Board: Ophthalmology Department, Singleton Hospital
  Swansea, United Kingdom Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Early vitrectomy with PRP for early proliferative diabetic retinopathy

  Tests whether early microincision vitrectomy surgery combined with PRP can improve regrowth of abnormal blood vessels and vision in people with early proliferative diabetic retinopathy.

  Recruiting Xiamen Ophthalmology Center Affiliated to Xiamen University · Beijing, Beijing Municipality and 5 other locations · NCT07586787

• Faricimab plus PRP versus vitrectomy with endolaser for proliferative diabetic retinopathy

  This trial will test whether faricimab plus panretinal photocoagulation (PRP) or vitrectomy with endolaser gives better long-term vision and fewer follow-up treatments for adults with proliferative diabetic retinopathy.

  Recruiting at 34 sites Phase 3 Jaeb Center for Health Research · Huntington Beach, California and 33 other locations · NCT06790784

• Gene therapy for diabetic eye disease after surgery

  This study is testing a new gene therapy for people with diabetic eye disease after surgery to see if it can help slow down the disease and reduce complications.

  Recruiting Early Phase 1 Tianjin Medical University Eye Hospital · Tianjin · NCT06412224

• ANXV (Annexin A5) infusions for non-proliferative diabetic retinopathy and retinal vein occlusion

  This will test whether short daily infusions of ANXV can be given safely and help improve vision or reduce the need for rescue medication in adults with recent-onset non-proliferative diabetic retinopathy or retinal vein occlusion.

  Recruiting Phase 2 Annexin Pharmaceuticals AB · London · NCT07259928

• OTX-TKI (axitinib intravitreal implant) for non-proliferative diabetic retinopathy

  This trial will test whether a long-acting axitinib hydrogel implant injected into one eye can slow worsening in adults with moderately severe to severe non-proliferative diabetic retinopathy.

  Recruiting Phase 3 Ocular Therapeutix, Inc. · Hagerstown, Maryland · NCT07235085

• Evaluating TNTL for treating non-proliferative diabetic retinopathy

  This study is testing if a new drug called TNTL can help adults with non-proliferative diabetic retinopathy see better and stay safe compared to a placebo.

  Recruiting at 30 sites Phase 3 Beletalent (Zhuhai) Pharmaceutical Co., Ltd · Xuancheng, Anhui and 29 other locations · NCT06817265

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.